Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer.
Miura H, Yamamoto H, Okuyama Y, Ishi N, Tanaka R, Oishi T, Yoneyama F, Hamaya T, Togashi K, Fujita N, Okamoto T, Ohyama C, Hatakeyama S.
Miura H, et al. Among authors: oishi t.
Cancer Med. 2024 Dec;13(24):e70226. doi: 10.1002/cam4.70226.
Cancer Med. 2024.
PMID: 39676240
Free PMC article.